Reports and Findings

We analysed the stimulation of J8 antibodies in response to infection, and the role of existing J8 antibodies in protection against subsequent infection

A vaccine that prevents GAS cellulitis and other skin infections, in addition to throat infections, would maximise its value and commercial viability

Population-based primary prevention of ARF through sore throat management may be effective in well-resourced settings like New Zealand

Severe lower leg cellulitis presents a major burden to the health sector and is increasing with an ageing population

Severe lower leg cellulitis recurrences are frequent, and each episode increases the likelihood of subsequent recurrence and length of hospitalization

The authors present a variety of pressing clinical research questions on optimal RHD prevention and advanced care

Improved public health measures targeting bacterial skin infections are needed to reduce this high burden of skin infections in Western Australia

This work will be undertaken in collaboration with The Kids Research Institute Australia and Australian based research teams to better understand how Penicillin works in Māori and Pacific children/teens who receive monthly BPG injections.

Reach works to promote the health of vulnerable populations by providing technical support to local, regional and global efforts to prevent and control rheumatic fever and rheumatic heart disease (RF/RHD).

Our findings are crucial in demonstrating that the Northern Territory STS clone is not STX resistant